BRAF-mutated malignant melanoma with chondrosarcomatous differentiation in inguinal nodal metastasis

被引：1

作者：

Abbati, Francesca ^{[1
]}

Altimari, Annalisa ^{[2
]}

Corti, Barbara ^{[3
]}

Dika, Emi ^{[4
]}

Sperandi, Francesca ^{[1
]}

Melotti, Barbara ^{[5
]}

机构：

[1] Univ Bologna, IRCCS Azienda Osped, Dept Med Oncol, Bologna, Italy

[2] Univ Bologna, IRCCS Azienda Osped, Lab Oncol Mol Pathol, Bologna, Italy

[3] Univ Bologna, St Orsola Malpighi Hosp, Dept Diagnost Med & Prevent, Pathol Unit, Bologna, Italy

[4] Univ Bologna, Dept Expt Diagnost & Specialty Med, Dermatol, Bologna, Italy

[5] IRCCS Azienda Osped Univ St Orsola, Malpighi Hosp, Dept Med Oncol, Bologna, Italy

来源：

CLINICAL CASE REPORTS | 2021年 / 9卷 / 04期

关键词：

BRAF mutation; chondrosarcomatous differentiation; melanoma;

D O I：

10.1002/ccr3.3982

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We report the case of a young woman who developed metastatic melanoma in the inguinal nodal region, which acquired chondrosarcomatous differentiation and preserved the BRAF mutation found in the primary tumor. The patient was treated with a BRAF/MEK inhibitor combination therapy (dabrafenib/trametinib), which was demonstrated to be effective and well-tolerated.

引用

页码：2200 / 2204

页数：5

共 50 条

[21] Chondrosarcomatous Differentiation in a Large Malignant Melanoma of the Scalp
Alderson, Colin S.
Douglas, Helen E.
Rollett, Rebecca
Mathew, Bipin
Matteucci, Paolo
[J]. CASE REPORTS IN MEDICINE, 2016, 2016
[22] Improved Survival with MEK Inhibition in BRAF-Mutated Melanoma
Flaherty, Keith T.
Robert, Caroline
Hersey, Peter
Nathan, Paul
Garbe, Claus
Milhem, Mohammed
Demidov, Lev V.
Hassel, Jessica C.
Rutkowski, Piotr
Mohr, Peter
Dummer, Reinhard
Trefzer, Uwe
Larkin, James M. G.
Utikal, Jochen
Dreno, Brigitte
Nyakas, Marta
Middleton, Mark R.
Becker, Juergen C.
Casey, Michelle
Sherman, Laurie J.
Wu, Frank S.
Ouellet, Daniele
Martin, Anne-Marie
Patel, Kiran
Schadendorf, Dirk
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (02): : 107 - 114
[23] Distribution of BRAF-mutated and BRAF-wild tumor cells in the melanoma tissues
Sakaizawa, Kaori
Ashida, Atsuko
Okuyama, Ryuhei
[J]. CANCER SCIENCE, 2018, 109 : 343 - 343
[24] FDA Approves Adjuvant Dabrafenib/Trametinib in BRAF-Mutated Melanoma
Schuyler, Devon
[J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2018, 16 (06) : 397 - 397
[25] Severe vitamin D deficiency associated with BRAF-mutated melanoma
Fearfield, L.
Nobbs, J.
Petruckevitch, A.
Harland, C.
[J]. BRITISH JOURNAL OF DERMATOLOGY, 2019, 181 (06) : 1343 - 1343
[26] Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients
Ryan J. Sullivan
Omid Hamid
Rene Gonzalez
Jeffrey R. Infante
Manish R. Patel
F. Stephen Hodi
Karl D. Lewis
Hussein A. Tawbi
Genevive Hernandez
Matthew J. Wongchenko
YiMeng Chang
Louise Roberts
Marcus Ballinger
Yibing Yan
Edward Cha
Patrick Hwu
[J]. Nature Medicine, 2019, 25 : 929 - 935
[27] The Current State of Molecular Testing in the BRAF-Mutated Melanoma Landscape
Vanni, Irene
Tanda, Enrica Teresa
Spagnolo, Francesco
Andreotti, Virginia
Bruno, William
Ghiorzo, Paola
[J]. FRONTIERS IN MOLECULAR BIOSCIENCES, 2020, 7
[28] Atezolizumab plus cobimetinib and vemurafenib in BRAF-mutated melanoma patients
Sullivan, Ryan J.
Hamid, Omid
Gonzalez, Rene
Infante, Jeffrey R.
Patel, Manish R.
Hodi, F. Stephen
Lewis, Karl D.
Tawbi, Hussein A.
Hernandez, Genevive
Wongchenko, Matthew J.
Chang, YiMeng
Roberts, Louise
Ballinger, Marcus
Yan, Yibing
Cha, Edward
Hwu, Patrick
[J]. NATURE MEDICINE, 2019, 25 (06) : 929 - +
[29] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
Pier Francesco Ferrucci
Marko Lens
Emilia Cocorocchio
[J]. Current Oncology Reports, 2021, 23
[30] Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients
Ferrucci, Pier Francesco
Lens, Marko
Cocorocchio, Emilia
[J]. CURRENT ONCOLOGY REPORTS, 2021, 23 (12)

← 1 2 3 4 5 →